Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-24 5:19 pm Sale | 13D | ALLURION TECHNOLOGIES INC ALUR | RTW INVESTMENTS LP | 3,666,589 5.7% | -749,998 (-16.98%) | View |
2024-08-23 5:46 pm Purchase | 13D | Avidity Biosciences Inc. RNA | RTW INVESTMENTS LP | 12,079,734 9.99% | 2,419,925 (+25.05%) | View |
2024-08-07 5:19 pm Purchase | 13D | ORCHESTRA BIOMED HOLDINGS, INC OBIO | RTW INVESTMENTS LP | 7,704,030 21.5% | 2,083,385 (+37.07%) | View |
2024-07-02 5:51 pm Purchase | 13D | ALLURION TECHNOLOGIES INC ALUR | RTW INVESTMENTS LP | 4,416,587 7% | 479,684 (+12.18%) | View |
2024-04-17 6:57 pm Purchase | 13D | ALLURION TECHNOLOGIES INC ALUR | RTW INVESTMENTS LP | 3,936,903 8.1% | 3,936,903 (New Position) | View |
2024-03-01 4:15 pm Purchase | 13D | Avidity Biosciences Inc. RNA | RTW INVESTMENTS LP | 9,659,809 9.99% | 2,958,320 (+44.14%) | View |
2024-02-14 07:57 am Purchase | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | RTW INVESTMENTS LP | 6,096,387 12.3% | 537,065 (+9.66%) | View |
2024-02-14 07:55 am Purchase | 13G | IMMUNIC INC IMUX | RTW INVESTMENTS LP | 4,335,255 9.6% | 473,965 (+12.27%) | View |
2024-02-14 07:53 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RTW INVESTMENTS LP | 5,469,956 8.8% | 476,677 (+9.55%) | View |
2024-02-14 07:52 am Sale | 13G | PMV Pharmaceuticals Inc. PMVP | RTW INVESTMENTS LP | 0 0% | -4,356,920 (Position Closed) | View |
2024-02-14 07:49 am Sale | 13G | RELMADA THERAPEUTICS INC. RLMD | RTW INVESTMENTS LP | 0 0% | -2,067,824 (Position Closed) | View |
2024-02-14 07:47 am Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | RTW INVESTMENTS LP | 5,315,514 9.2% | 1,723,528 (+47.98%) | View |
2024-02-14 07:46 am Purchase | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW INVESTMENTS LP | 6,887,086 8.4% | 2,920,171 (+73.61%) | View |
2024-02-14 07:44 am Purchase | 13G | Stoke Therapeutics Inc. STOK | RTW INVESTMENTS LP | 4,131,045 9.3% | 260,064 (+6.72%) | View |
2024-02-14 07:42 am Purchase | 13G | Vericel Corp VCEL | RTW INVESTMENTS LP | 3,212,794 6.7% | 112,890 (+3.64%) | View |
2024-02-14 07:40 am Purchase | 13G | ESTABLISHMENT LABS HOLDINGS INC. ESTA | RTW INVESTMENTS LP | 2,494,138 9.7% | 120,000 (+5.05%) | View |
2024-02-14 07:38 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 3,463,201 6.3% | 378,986 (+12.29%) | View |
2024-02-14 07:35 am Sale | 13G | C4 Therapeutics Inc. CCCC | RTW INVESTMENTS LP | 0 0% | -2,819,472 (Position Closed) | View |
2024-02-14 07:34 am Sale | 13G | BRAINSWAY LTD SPONSORED ADS BWAY | RTW INVESTMENTS LP | 0 0% | -3,204,762 (Position Closed) | View |
2024-02-14 07:32 am Sale | 13G | APYX MED CORP COM APYX | RTW INVESTMENTS LP | 1,025,963 3% | -2,372,316 (-69.81%) | View |